APA

Gökbuget N., Kelsh M., Chia V., Advani A., Bassan R., Dombret H., Doubek M., Fielding A. K., Giebel S., Haddad V., Hoelzer D., Holland C., Ifrah N., Katz A., Maniar T., Martinelli G., Morgades M., O'Brien S., Ribera J., Rowe J. M., Stein A., Topp M., Wadleigh M. & Kantarjian H. (2016). Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. : Blood cancer journal.

Chicago

Gökbuget N, Kelsh M, Chia V, Advani A, Bassan R, Dombret H, Doubek M, Fielding A K, Giebel S, Haddad V, Hoelzer D, Holland C, Ifrah N, Katz A, Maniar T, Martinelli G, Morgades M, O'Brien S, Ribera J-M, Rowe J M, Stein A, Topp M, Wadleigh M and Kantarjian H. 2016. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. : Blood cancer journal.

Harvard

Gökbuget N., Kelsh M., Chia V., Advani A., Bassan R., Dombret H., Doubek M., Fielding A. K., Giebel S., Haddad V., Hoelzer D., Holland C., Ifrah N., Katz A., Maniar T., Martinelli G., Morgades M., O'Brien S., Ribera J., Rowe J. M., Stein A., Topp M., Wadleigh M. and Kantarjian H. (2016). Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. : Blood cancer journal.

MLA

Gökbuget N, Kelsh M, Chia V, Advani A, Bassan R, Dombret H, Doubek M, Fielding A K, Giebel S, Haddad V, Hoelzer D, Holland C, Ifrah N, Katz A, Maniar T, Martinelli G, Morgades M, O'Brien S, Ribera J-M, Rowe J M, Stein A, Topp M, Wadleigh M and Kantarjian H. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. : Blood cancer journal. 2016.